BioSpace News Archive

Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, announces completion of a successful pharmacokinetic study for Mycapssa®.

First Wave BioPharma, Inc. announced, that James Sapirstein, Chairman and Chief Executive Officer, will participate in a “fireside chat” with Jonathan Aschoff, Ph.D., Managing Director and Senior Research Analyst at Roth Capital Partners, during the 34th Annual ROTH Conference taking place March 13-15, 2022, at The Ritz Carlton, Laguna Niguel located in Dana Point, California.

Harvard Bioscience, Inc. announced financial results for the period ended December 31, 2021.

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes announced it will be presenting clinical data at the upcoming SAGES 2022 Annual Meeting, being held on March 16-19, 2022 in Denver, Colorado.

Travere Therapeutics, Inc. announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2029 in an underwritten offering.

Creyon Bio, Inc., a drug development company engineering RNA-based medicines and their components with predictable safety and efficacy profiles, launched with the goal of making precision medicines on demand a real possibility for populations ranging from one patient to millions.

ANANDA Scientific Inc . today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S , an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 8:00 a.m. ET.

Akili Interactive Labs, Inc., a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, announced it has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies for 2022.

Rocket Pharmaceuticals, Inc. today announces the appointment of Jessie Yeung as Vice President of Investor Relations and Corporate Finance.